PMCF Study of the AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair

NCT05304819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2026-04-21

No results posted yet for this study

Summary

This is a Post Market Clinical Follow Up Study in Orthopaedics, it will verify the long-term safety and performance of the device in the intended patient population, when indicated for the acute repair of the Achilles tendon.

The Medical Device in this study AchilloCordPLUS is a Class IIb UKCA-Marked device manufactured by Xiros Ltd.

Conditions

  • Achilles Tendon Rupture

Interventions

DEVICE

AchilloCordPLUS™ System Implant

AchilloCordPLUS System Implant Set for Acute Achilles Tendon Repair

Sponsors & Collaborators

  • Xiros Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-09
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05304819 on ClinicalTrials.gov